Vimarsana
Biggest News Aggregation in the World

Eric Rowinsky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eric Rowinsky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eric Rowinsky Today - Breaking & Trending Today

Purple Biotech : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K - Vimarsana News

Purple Biotech : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K

Bonuses 4.2.1. General Terms ... | May 1, 2023

Purple Biotech Reports Temporary Medical Leave of CEO Gil Efron - Vimarsana News

Purple Biotech Reports Temporary Medical Leave of CEO Gil Efron

Board of Directors appoints Isaac Israel, Board member and former CEO, as acting CEOCompany’s business plan and clinical development programs continue as planned REHOVOT, Israel, March 24, 2023 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (

Hummingbird Bioscience Holds Opening Ceremony for Singapore Science Park Office and Research Facilities - Vimarsana News

Hummingbird Bioscience Holds Opening Ceremony for Singapore Science Park Office and Research Facilities

/PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for...

Purple Biotech Appoints Life Sciences Industry Investor Ori Hershkovitz to its Board of Directors - Vimarsana News

Purple Biotech Appoints Life Sciences Industry Investor Ori Hershkovitz to its Board of Directors

REHOVOT, Israel, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor

Source: kulr8.com
Hummingbird Bioscience Announces First Patient Dosed in Phase 1 Clinical Trial of HMBD-001 in Advanced HER3-Expressing Solid Malignancies - Vimarsana News

Hummingbird Bioscience Announces First Patient Dosed in Phase 1 Clinical Trial of HMBD-001 in Advanced HER3-Expressing Solid Malignancies

/PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets in...